AdaptHealth (AHCO) To Report Earnings Tomorrow: Here Is What To Expect

Healthcare services provider AdaptHealth Corp. (NASDAQ:AHCO) will be reporting earnings this Tuesday before the bell. Here’s what you need to know.

AdaptHealth beat analysts’ revenue expectations by 1.7% last quarter, reporting revenues of $777.9 million, down 1.8% year on year. It was a slower quarter for the company, with a significant miss of analysts’ EPS estimates and full-year revenue guidance slightly missing analysts’ expectations.

Is AdaptHealth a buy or sell going into earnings? Read our full analysis here, it’s free.

This quarter, analysts are expecting AdaptHealth’s revenue to be flat year on year at $804 million, slowing from the 1.6% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.16 per share.

The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. AdaptHealth has missed Wall Street’s revenue estimates twice over the last two years.

Looking at AdaptHealth’s peers in the senior health, home health & hospice segment, some have already reported their Q2 results, giving us a hint as to what we can expect. BrightSpring Health Services delivered year-on-year revenue growth of 15.3%, beating analysts’ expectations by 5.2%, and Option Care Health reported revenues up 15.4%, topping estimates by 4.6%. Option Care Health traded down 2.7% following the results.

Read our full analysis of BrightSpring Health Services’s results here and Option Care Health’s results here.

The euphoria surrounding Trump’s November win lit a fire under major indices, but potential tariffs have caused the market to do a 180 in 2025. While some of the senior health, home health & hospice stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 4.3% on average over the last month. AdaptHealth is down 5.4% during the same time and is heading into earnings with an average analyst price target of $12.88 (compared to the current share price of $8.75).

Unless you’ve been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.